| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 241.51 | 2.1% | 3.9% |
| Total Income | 245.36 | 0.7% | 4.5% |
| Expenditure | 215.63 | 1.7% | 2.6% |
| PBT | 29.73 | 14.8% | 120.8% |
| Net Profit | 21.58 | 21.8% | 167.5% |
| OPM | 20.38% | 0.08pp | 3.30pp |
| NPM | 8.79% | 2.38pp | 5.35pp |
| EPS | 2.88 | 22.4% | 154.9% |
Margin Recovery Can't Hide Revenue Stall
Reported profit surged 167.5%, but operating revenue grew just 3.9%—a critical miss against the prior 14% industry benchmark. With retention down and same-store growth halved, the fundamentals behind management's '3-4 quarter recovery' narrative need scrutiny.
₹21.6 Cr
+167.5% YoY
₹241.5 Cr
+3.9% YoY vs. 14% target
20.4%
+331 bps YoY
90.5%
vs. prior 93-94%
Profit surged, but revenue stalled
Q2 reported PAT of ₹21.6 Cr jumped 167.5% year-on-year, lifted by Paramount integration lapping and margin expansion. But peel back the headline: operating revenue grew just 3.9%—a deep miss against management's prior claim of '14% industry growth or better.' TPA revenue, the core business, expanded only 1.2% in Q2, the slowest rate of the recent cycle. Management invokes a 3-4 quarter accounting lag on installment premium recognition, citing contract liability of ₹321.7 Cr (vs. ₹280.2 Cr in FY26). If true, this deferred revenue will catch up. But the underlying TPA growth dynamic has fundamentally slowed—same-store growth halved from 13-14% to 7-8%, driven by IT-ITeS headcount saturation and benefit inflation in the market.
Where the profit came from
The PAT lift is real, but its drivers matter for the outlook. Q2 margin expanded 331 basis points to 20.4%, delivered on management's four-quarter Paramount integration promise. But much of the profit growth is non-recurring: H1 PAT benefited from a one-time derivative gain on call-put options, and the comparison is easy because Paramount churn was severe in prior-year Q2. Strip these out, and organic H1 PAT of roughly ₹46 Cr (vs. reported ₹49.2 Cr) grows only about 50% from prior H1's ₹30.7 Cr—still solid, but not the 167% headline.
Core business growth 'in line with or better than industry (14%)'
ContradictedQ2 operating revenue +3.9% YoY; India TPA +11.9% H1 but only +1.2% Q2
Paramount integration complete Q2 with 330 bps margin improvement
SupportedIntegration complete; 331 bps EBITDA margin expansion achieved YoY
Technology scaling 55% YoY, targeting ~10% of revenue
PartialPlatform ₹19.8 Cr H1 (4.2% of consolidated), 69.8% growth; still far from target
Retention recovering to 93-94% in 3-4 quarters
PartialH1 retention 90.5%; improvement Q/Q but timeline extended
International business expanding, Thailand platform live
PartialH1 international growth only 1.1% YoY; early-stage, no material near-term impact
What changed from prior guidance
Management has reset the growth narrative without providing numbers. Prior call promised '14% industry growth or better'; this call backed away to 'per or faster than market' with no numeric target. Margin steady-state target remains 22-23%, implying 180+ basis points of uplift still to come from the current 20.4%. Retention recovery is now a 3-4 quarter process (previously implied Q2 normalization), citing both Paramount churn and a December cyber incident as persistent headwinds. Same-store growth structural decline from 13-14% to 7-8% is reframed as an industry-wide dynamic (IT-ITeS saturation, benefit inflation), but no offset strategy was articulated. International business remains flat at 1.1% H1 growth despite Thailand platform launch—early stage, no near-term catalyst.
Bull-bear ledger
Paramount integration margin lift delivered (330 bps), on schedule
PAT grew 167.5% YoY, showing operational leverage
Group market share improved to 34.1%; scale advantage intact
Zero debt; cash ₹268.3 Cr; net worth ₹886.8 Cr; strong balance sheet
Technology platform at scale (7M claims H1); long-term SaaS runway exists
Revenue growth missed guidance badly (3.9% Q2 vs. 14% prior claim)
TPA core growth collapsed to 1.2% Q2, raising questions on accounting lag narrative
Retention down to 90.5% from 93-94%; recovery timeline vague (3-4 quarters)
Same-store growth halved to 7-8% from 13-14%; structural headwind unaddressed
Technology monetization delayed; still 4.2% of revenue vs. 10% target
Management guidance reset without numbers; no quantified FY27 targets
Ranked risks (by concern to a holder)
TPA growth accounting lag masks structural deceleration
HighQ2 TPA growth only 1.2% YoY (₹219.6 Cr). Management cites 3-4 quarter revenue recognition lag on installment premiums with ₹321.7 Cr contract liability. If deferred revenue doesn't materialize as claimed, or if core TPA growth stays below 8%, the guidance miss becomes permanent, not temporary.
Retention recovery timeline extended and uncertain
HighH1 retention at 90.5% vs. prior 93-94%. Paramount churn and December cyber incident cited. 3-4 quarter recovery expected but no interim milestones provided. Group business is 70% of revenue; sustained retention pressure would erode market share and pricing power.
Same-store growth structural decline unaddressed
MediumGroup same-store growth halved from 13-14% to 7-8%, attributed to IT-ITeS headcount saturation and benefit inflation. Management framed as industry-wide but offered no offset. If this is permanent, core growth ceiling is now 8-10% at best, far below prior 14% benchmark.
Guidance reset without numeric targets
MediumPrior call: '14% industry growth or better.' This call: 'per or faster than market' (no number). Margin target remains 22-23% but requires 180+ bps uplift from current 20.4%. Lack of specificity reduces accountability and visibility.
Technology monetization delayed and early-stage
MediumPlatform revenue only ₹19.8 Cr H1 (4.2% of consolidated), growing strongly (69.8%) but still far from 10% target. Management states contracts are 'kicking in slowly' with 5-10x revenue-per-claim potential unproven. At current run-rate, technology won't be material for 2+ years.
How the market is positioned
The stock fell to ₹285.75, now trading 60% below its all-time high of ₹716.15 and below all major moving averages (SMA20 ₹295.45, SMA50 ₹312.48, SMA200 ₹352.12). RSI at 37.3 signals neutral-to-oversold, but volume is increasing—a sign of selling pressure, not capitulation. FII holdings increased 1.1 percentage points Q/Q to 25.42%, suggesting modest accumulation into weakness, while DII trimmed 1.95 percentage points to 47.24%. The bulk deal by NT Asian Discovery Master Fund at ₹356.76 (21% above current price) hints at institutional support, but the downtrend from ATH remains intact. The market's verdict: the margin recovery was delivered as promised, but the revenue miss and guidance reset are material misses. Price action confirms the fundamental read—growth deceleration is not priced as temporary.
What to watch next
1 · Q3 TPA revenue growth and contract liability realization
If revenue recognition catch-up from contract liability (₹321.7 Cr) materializes in Q3-Q4 as management claims, TPA revenue should accelerate meaningfully. Track whether Q3 TPA growth accelerates above 8-10%—if it stays below 5%, the accounting lag narrative breaks and growth is structurally soft.
2 · Retention trajectory in Q3-Q4 FY27
Management expects retention to recover to 93-94% in 3-4 quarters. Q3 results will show whether the trend reversed in H2. If retention stays at 90% or deteriorates further, the 3-4 quarter recovery claim is invalid and competitive pressure runs deeper.
3 · Technology contract revenue realization
Four new insurer contracts onboarded this quarter with claimed 5-10x revenue-per-claim potential. Q3-Q4 will show whether these begin translating to material revenue, or if monetization remains stuck in 'early days' narrative. Technology must reach 6-7% of revenue by H1 FY28 to be on track to the 10% target.
The rating
Hold. Medi Assist delivered on margin recovery and demonstrated operational execution (Paramount integration, zero debt, strong balance sheet). But the revenue miss is material: Q2 operating revenue grew 3.9% against a prior claim of '14% industry growth or better,' and the core TPA business expanded just 1.2%, the slowest in recent memory. Management's '3-4 quarter recovery' narrative—for retention, revenue recognition timing, and margin uplift—is a hope pattern without interim milestones. Same-store growth has halved from 13-14% to 7-8% with no offset strategy. Technology is a multi-year play, not a near-term catalyst. The market has repriced the stock 60% from ATH, below all major moving averages, and volume is increasing. Retain for long-term believers in the Paramount integration and technology platform, but do not add until growth stabilizes above mid-single digits and management provides quantified guidance. The single number to track: Q3 TPA revenue growth—if that stays below 8%, the consensus case breaks.
Medi Assist's Q2 was a steady quarter masked by margin recovery. The margin expansion was real and delivered on the Paramount integration promise. But the revenue stall is undeniable—TPA growth only 1.2% Q2 is not a timing issue, it's a signal that the core business is decelerating structurally. Retention is down, same-store growth is halved, and management has reset guidance without providing numbers. The '3-4 quarter recovery' narrative needs verification in Q3, especially on revenue recognition catch-up and retention reversal. Hold pending clarity on whether growth can stabilize above mid-single digits.
Margin target hit, revenue growth deeply missed 14% guidance
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Paramount integration delivered as promised (330 bps recovery). Growth guidance 'in line with industry' unmet in Q2 (3.9% vs. 14%). No numeric FY27 guidance provided to assess.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Medi Assist delivered on margin recovery (20.4% EBITDA, +331 bps YoY) and PAT grew 167.5%, but Q2 revenue growth of 3.9% significantly misses the prior 14% industry benchmark. Management invokes 3-4 quarter accounting lags and Paramount churn for soft near-term growth; technology scaling and international expansion remain early-stage. Margin target of 22-23% steady-state not yet visible. Hold pending clarity on growth trajectory.
₹241.5 Cr
Revenue · +3.9% YoY₹21.6 Cr
Reported PAT · +167.5% YoYExpanding
Margins · vs guidance: MixedDid the claims hold up?
Core business growth in line with or better than 14% industry
MISSQ2 operating revenue 3.9% YoY, H1 13.8% consolidated — both below 14%
Paramount integration complete Q2 with 330 bps margin improvement
METIntegration complete, 331 bps EBITDA margin expansion achieved YoY
Technology scaling 55% YoY, targeting ~10% of revenue
PartialPlatform ₹19.8 Cr in H1 (4.2% of consolidated), strong growth but still below 10% target
International business expanding, first Thailand contract live
METPlatform live in Southeast Asia, but H1 growth only 1.1% YoY, flat
Retention recovering from Paramount churn, will reach 93-94% in 3-4 quarters
PartialH1 retention at 90.5%, improvement QoQ, but 3-4 quarter lag cited repeatedly
Earnings quality
What changed since the last call
Revenue growth guidance missed
DowngradePrior '14% industry growth or better'; Q2 actual 3.9% YoY operating revenue. H1 13.8% consolidated but much on smaller base post-Paramount carve-out.
Margin recovery confirmed
Upgrade20.4% Q2 EBITDA margin expanded 331 bps YoY; matched '330 bps over 4 quarters' prior claim. Paramount integration boost delivered.
Retention pressure persistent
DowngradeH1 90.5% retention vs. prior 93-94%; Paramount churn and cyber incident cited. Recovery now expected 3-4 quarters out (previously claimed Q2 completion would normalize).
Same-store growth downshifted
DowngradeGroup same-store growth now 7-8% vs. historical 13-14%; market inflation and benefit saturation cited. No near-term recovery expected.
International growth stalled
DowngradeH1 growth only 1.1% YoY despite Thailand platform launch; early-stage, no near-term impact.
The Q&A
Q&A showed analysts pressing hard on weak Q2 TPA growth (1.2% YoY), retention drop-down, and why technology investments haven't improved group retention. Management held firm on 3-4 quarter recovery narrative, accounting timing, and cyber/Paramount churn explanations, but tone was defensive, not confident.
Growth & same-store trajectory — Navid Virani, Bastion Research
PartialGroup business grew 21% in H1, driven by market share gain and pricing. Same-store growth 8%-9% range going forward (down from 13%-14% historical). Expect retention recovery to 93%-94% in 3-4 quarters to boost growth.
TPA growth slowdown — Vikas Sharda, NT Asset Management
PartialAccounting timing — installment premiums recognized over 3-4 quarters; contract liability ₹40-50 Cr revenue equiv. Recognition will catch up in coming quarters. Confident in growth per or faster than market.
Paramount integration & margin normalization — Prithvish Uppal, Nuvama
Partial100% of corporates now on unified platform, full integration, 800+ headcount reduction post-Paramount. Margin steady-state 22%-23% in core business. Q2 at 20.4%; cyber incident in December and migration complexity drove some losses, accounts beginning to come back.
Technology segment scale — Dihraj Kaswan, Incred
AnsweredMost revenue now pure SaaS platform. Contracts kicking in slowly with 5-10x potential per claim vs. current SaaS revenue. Early days but solutions fully independent of TPA offering, available for in-house use by insurers.
Group retention puzzle — Mihir Shah, Meritus
PartialNot every account is viable commercially. Also accounting—some clients not in reporting yet, some left due to pricing/scope, some moved providers. Margin includes overlapping costs of international/tech buildout. Core steady-state 22%-23% achievable once investments monetize and scale.
Guidance
Core business growth in line with or better than industry (~14%)
LowQ2 actual 3.9% YoY; H1 13.8%. India TPA 11.9% YoY in H1 vs. claimed 14% target. Unmet.
Steady-state margin 22%-23% in core business
MediumQ2 at 20.4%, H1 at 20.3%. Management cites overlapping costs from tech/international buildout. Implies margin uplift of 200+ bps still needed.
Risks the call surfaced
Retention & churn
HighH1 retention 90.5% vs. prior 93-94%. Paramount migration churn and cyber incident (Dec post-Paramount) cited. Recovery timeline extended to 3-4 quarters with no guarantee. Group business 70% of revenue.
Growth slowdown
MediumQ2 TPA growth only 1.2% YoY (₹219.6 Cr). Same-store growth declined to 7-8% vs. 13-14% historical due to benefit inflation and IT-ITeS headcount saturation. Industry growing ~14%.
Technology monetization
MediumPlatform revenue only ₹19.8 Cr in H1 (4.2% of consolidated), growth strong but still far from 10% target. Contracts 'kicking in slowly' per management. Revenue potential stated as 5-10x current per-claim rate but unproven.
International expansion
LowInternational revenue ₹20.7 Cr in H1 with only 1.1% growth, flat despite platform live in Southeast Asia. Early-stage, no material near-term contribution.
Accounting timing & visibility
MediumManagement cites 3-4 quarter revenue recognition lag for installment premiums. Contract liability ₹321.7 Cr (vs. ₹280.2 Cr FY26) represents deferred revenue equiv. ₹40-50 Cr per quarter. If realized slower than expected, growth guidance may slippage further.
Management
Score 6/10. Transparent on challenges (Paramount churn, cyber incident, accounting lag) but hedge heavily on forward guidance. Repeatedly cite 3-4 quarter recovery timelines without firm commitments. Candid on margin steady-state (22-23%) vs. current (20.4%). Paramount integration delivered on schedule (330 bps margin recovery achieved). Q2 PAT growth 167.5% strong, but revenue miss 3.9% vs. 14% target. Track record mixed: margin met, growth missed.
1 · Q3-Q4 FY27
Retention recovery begins; management cites 3-4 quarter normalization post-Paramount churn
2 · H2 FY27
Technology platform revenues to accelerate; 4 insurers onboarded this quarter, contracts with 5-10x current claim revenue potential
3 · FY28+
International expansion (Southeast Asia platform live, retail & group membership growing outside India)
Hold pending clarity on growth trajectory.